Hosted on MSN15d
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
Shares of Mesoblast Limited MESO have soared 80% in one month following the FDA approval of remestemcel-L as the only ...
Benzinga.com1mon
What's Going On With Mesoblast Shares Thursday?
Mesoblast announces that the FDA approved Ryoncil. Ryoncil is the only approved therapy for steroid-refractory acute graft versus host disease. Mesoblast Limited MESO stock is trading higher ...
Mesoblast price target raised to $30 from $18 at Maxim
Maxim raised the firm’s price target on Mesoblast (MESO) to $30 from $18 and keeps a Buy rating on the shares after the FDA approved Ryoncil as ...
Yahoo Finance1mon
MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease
Mesoblast Limited MESO announced that the FDA has approved Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in children aged two months ...
Yahoo Finance15d
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
Shares of Mesoblast Limited MESO have soared 80% in one month following the FDA approval of remestemcel-L as the only approved therapy for steroid-refractory acute graft versus host disease (SR ...